Stephen C. Wilkie

534 total citations
6 papers, 456 citations indexed

About

Stephen C. Wilkie is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Stephen C. Wilkie has authored 6 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Stephen C. Wilkie's work include Carbohydrate Chemistry and Synthesis (6 papers), Microbial Natural Products and Biosynthesis (5 papers) and Probiotics and Fermented Foods (3 papers). Stephen C. Wilkie is often cited by papers focused on Carbohydrate Chemistry and Synthesis (6 papers), Microbial Natural Products and Biosynthesis (5 papers) and Probiotics and Fermented Foods (3 papers). Stephen C. Wilkie collaborates with scholars based in United States. Stephen C. Wilkie's co-authors include R. C. Thompson, Nancy Snyder, Mark J. Zweifel, DEBORAH L. MULLEN, Thalia I. Nicas, Patti Matsushima, Patricia J. Solenberg, Richard H. Baltz, Michael Rodriguez and Thomas F. Butler and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics and Chemistry & Biology.

In The Last Decade

Stephen C. Wilkie

6 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen C. Wilkie United States 5 262 225 189 157 53 6 456
R. NAGARAJAN United States 9 276 1.1× 190 0.8× 238 1.3× 178 1.1× 46 0.9× 10 577
Joyce Kohler United States 8 296 1.1× 200 0.9× 198 1.0× 143 0.9× 146 2.8× 9 545
Mark J. Zweifel United States 9 197 0.8× 182 0.8× 175 0.9× 202 1.3× 53 1.0× 17 469
Srinivas Kodali United States 9 271 1.0× 206 0.9× 162 0.9× 126 0.8× 81 1.5× 12 618
F Ripamonti Italy 10 289 1.1× 253 1.1× 208 1.1× 73 0.5× 29 0.5× 18 541
Nancy Snyder United States 11 215 0.8× 165 0.7× 174 0.9× 222 1.4× 74 1.4× 20 517
Thomas F. Butler United States 11 228 0.9× 150 0.7× 123 0.7× 170 1.1× 36 0.7× 18 479
KOZO TOMATSU Japan 12 241 0.9× 203 0.9× 246 1.3× 94 0.6× 72 1.4× 17 564
Michael J. Pucci United States 11 271 1.0× 108 0.5× 63 0.3× 261 1.7× 84 1.6× 14 521
G. BERETTA Italy 11 378 1.4× 370 1.6× 128 0.7× 120 0.8× 70 1.3× 20 717

Countries citing papers authored by Stephen C. Wilkie

Since Specialization
Citations

This map shows the geographic impact of Stephen C. Wilkie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Wilkie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Wilkie more than expected).

Fields of papers citing papers by Stephen C. Wilkie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Wilkie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Wilkie. The network helps show where Stephen C. Wilkie may publish in the future.

Co-authorship network of co-authors of Stephen C. Wilkie

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Wilkie. A scholar is included among the top collaborators of Stephen C. Wilkie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Wilkie. Stephen C. Wilkie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Rodriguez, Michael, Nancy Snyder, Mark J. Zweifel, et al.. (1998). Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci.. The Journal of Antibiotics. 51(6). 560–569. 45 indexed citations
2.
Solenberg, Patricia J., et al.. (1997). Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis. Chemistry & Biology. 4(3). 195–202. 145 indexed citations
3.
Nicas, Thalia I., DEBORAH L. MULLEN, J E Flokowitsch, et al.. (1996). Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.. The Journal of Antibiotics. 40. 2194–2199. 18 indexed citations
4.
Cooper, R. D. G., Nancy Snyder, Mark J. Zweifel, et al.. (1996). Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.. The Journal of Antibiotics. 49(6). 575–581. 151 indexed citations
5.
Nicas, Thalia I., DEBORAH L. MULLEN, J E Flokowitsch, et al.. (1996). Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy. 40(9). 2194–2199. 96 indexed citations
6.
Wilkie, Stephen C., Nancy Snyder, Mark J. Zweifel, et al.. (1995). New semisynthetic glycopeptide antibiotics Structure-activity relationship of the N-alkylated disaccharide. 35. 156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026